🟢 Oncolytics Biotech is trading 5.6% up in after-hours trading with no confirmed catalyst

Oncolytics Biotech is trading at $0.63, up 5.55% in after-hours trading; the catalyst remains unclear.

• It closed the regular session at $0.60 on October 5, 2026, after falling 5.40%; supplied price context shows a late-session reversal.
• No new company-specific announcement or confirmed catalyst for the after-hours rise was found; the latest identified company updates predate October 5.
• Broader market gains do not explain the stock’s opposite-direction regular-session move.